Cargando…

Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection

Severe acute respiratory syndrome (SARS) is a highly contagious infectious disease which first emerged in late 2002, caused by a then novel human coronavirus, SARS coronavirus (SARS-CoV). The virus is believed to have originated from bats and transmitted to human through intermediate animals such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Oi-Wing, Chia, Adeline, Tan, Anthony T., Jadi, Ramesh S., Leong, Hoe Nam, Bertoletti, Antonio, Tan, Yee-Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115611/
https://www.ncbi.nlm.nih.gov/pubmed/26954467
http://dx.doi.org/10.1016/j.vaccine.2016.02.063
_version_ 1783514134397059072
author Ng, Oi-Wing
Chia, Adeline
Tan, Anthony T.
Jadi, Ramesh S.
Leong, Hoe Nam
Bertoletti, Antonio
Tan, Yee-Joo
author_facet Ng, Oi-Wing
Chia, Adeline
Tan, Anthony T.
Jadi, Ramesh S.
Leong, Hoe Nam
Bertoletti, Antonio
Tan, Yee-Joo
author_sort Ng, Oi-Wing
collection PubMed
description Severe acute respiratory syndrome (SARS) is a highly contagious infectious disease which first emerged in late 2002, caused by a then novel human coronavirus, SARS coronavirus (SARS-CoV). The virus is believed to have originated from bats and transmitted to human through intermediate animals such as civet cats. The re-emergence of SARS-CoV remains a valid concern due to the continual persistence of zoonotic SARS-CoVs and SARS-like CoVs (SL-CoVs) in bat reservoirs. In this study, the screening for the presence of SARS-specific T cells in a cohort of three SARS-recovered individuals at 9 and 11 years post-infection was carried out, and all memory T cell responses detected target the SARS-CoV structural proteins. Two CD8(+) T cell responses targeting the SARS-CoV membrane (M) and nucleocapsid (N) proteins were characterized by determining their HLA restriction and minimal T cell epitope regions. Furthermore, these responses were found to persist up to 11 years post-infection. An absence of cross-reactivity of these CD8(+) T cell responses against the newly-emerged Middle East respiratory syndrome coronavirus (MERS-CoV) was also demonstrated. The knowledge of the persistence of SARS-specific celullar immunity targeting the viral structural proteins in SARS-recovered individuals is important in the design and development of SARS vaccines, which are currently unavailable.
format Online
Article
Text
id pubmed-7115611
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71156112020-04-02 Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection Ng, Oi-Wing Chia, Adeline Tan, Anthony T. Jadi, Ramesh S. Leong, Hoe Nam Bertoletti, Antonio Tan, Yee-Joo Vaccine Article Severe acute respiratory syndrome (SARS) is a highly contagious infectious disease which first emerged in late 2002, caused by a then novel human coronavirus, SARS coronavirus (SARS-CoV). The virus is believed to have originated from bats and transmitted to human through intermediate animals such as civet cats. The re-emergence of SARS-CoV remains a valid concern due to the continual persistence of zoonotic SARS-CoVs and SARS-like CoVs (SL-CoVs) in bat reservoirs. In this study, the screening for the presence of SARS-specific T cells in a cohort of three SARS-recovered individuals at 9 and 11 years post-infection was carried out, and all memory T cell responses detected target the SARS-CoV structural proteins. Two CD8(+) T cell responses targeting the SARS-CoV membrane (M) and nucleocapsid (N) proteins were characterized by determining their HLA restriction and minimal T cell epitope regions. Furthermore, these responses were found to persist up to 11 years post-infection. An absence of cross-reactivity of these CD8(+) T cell responses against the newly-emerged Middle East respiratory syndrome coronavirus (MERS-CoV) was also demonstrated. The knowledge of the persistence of SARS-specific celullar immunity targeting the viral structural proteins in SARS-recovered individuals is important in the design and development of SARS vaccines, which are currently unavailable. Elsevier Ltd. 2016-04-12 2016-03-05 /pmc/articles/PMC7115611/ /pubmed/26954467 http://dx.doi.org/10.1016/j.vaccine.2016.02.063 Text en Copyright © 2016 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ng, Oi-Wing
Chia, Adeline
Tan, Anthony T.
Jadi, Ramesh S.
Leong, Hoe Nam
Bertoletti, Antonio
Tan, Yee-Joo
Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
title Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
title_full Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
title_fullStr Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
title_full_unstemmed Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
title_short Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
title_sort memory t cell responses targeting the sars coronavirus persist up to 11 years post-infection
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115611/
https://www.ncbi.nlm.nih.gov/pubmed/26954467
http://dx.doi.org/10.1016/j.vaccine.2016.02.063
work_keys_str_mv AT ngoiwing memorytcellresponsestargetingthesarscoronaviruspersistupto11yearspostinfection
AT chiaadeline memorytcellresponsestargetingthesarscoronaviruspersistupto11yearspostinfection
AT tananthonyt memorytcellresponsestargetingthesarscoronaviruspersistupto11yearspostinfection
AT jadirameshs memorytcellresponsestargetingthesarscoronaviruspersistupto11yearspostinfection
AT leonghoenam memorytcellresponsestargetingthesarscoronaviruspersistupto11yearspostinfection
AT bertolettiantonio memorytcellresponsestargetingthesarscoronaviruspersistupto11yearspostinfection
AT tanyeejoo memorytcellresponsestargetingthesarscoronaviruspersistupto11yearspostinfection